Literature DB >> 8648034

Detection of IL-5 and IL-1 receptor antagonist in bronchoalveolar lavage fluid in acute eosinophilic pneumonia.

J N Allen1, Z Liao, M D Wewers, E A Altenberger, S A Moore, E D Allen.   

Abstract

BACKGROUND: Acute eosinophilic pneumonia is an idiopathic cause of respiratory failure, characterized by very high numbers of alveolar eosinophils without significant blood eosinophilia.
OBJECTIVE: The purpose of this study was to determine which cytokines are associated with acute eosinophilic pneumonia.
METHODS: Soluble IL-1 type II receptor and the cytokines IL-1 beta, IL-1ra, IL-3, IL-5, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha were measured in serum and in bronchoalveolar lavage fluid from two patients with acute eosinophilic pneumonia during both acute and convalescent phases.
RESULTS: Compared with patients with adult respiratory distress syndrome, the patients with acute eosinophilic pneumonia had high bronchoalveolar lavage fluid levels of IL-5, IL-1ra, and soluble type II IL-1 receptor but not IL-1 beta, tumor necrosis factor-alpha, IL-3, or granulocyte-macrophage colony-stimulating factor. Bronchoalveolar lavage fluid levels of IL-5 and IL-1ra fell after resolution of symptoms. In the serum of patients with acute eosinophilic pneumonia, IL-5 was not detectable, and IL-1ra was initially high but fell after corticosteroid treatment.
CONCLUSION: Acute eosinophilic pneumonia is characterized by locally high levels of IL-5, IL-1ra, and soluble type II IL-1 receptor in the alveolar space.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648034     DOI: 10.1016/s0091-6749(96)70206-3

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  12 in total

1.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

2.  Pediatric Acute Respiratory Distress Syndrome and Hypersensitivity Pneumonitis Related to E-cigarette Vaping.

Authors:  Binh Phung; Anh Lam
Journal:  J Pediatr Intensive Care       Date:  2019-11-28

Review 3.  Review.

Authors:  Daniel Hampton; Jane E Onken
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-08

Review 4.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 5.  Eosinophil-associated lung diseases. A cry for surfactant proteins A and D help?

Authors:  Julie G Ledford; Kenneth J Addison; Matthew W Foster; Loretta G Que
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

6.  Acute eosinophilic pneumonia following secondhand cigarette smoke exposure.

Authors:  Min Kyung Chung; Seok Jeong Lee; Mi Yeon Kim; Jin Hwa Lee; Jung Hyun Chang; Sung Shin Sim; Yon Ju Ryu
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

7.  Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study.

Authors:  Ranjini Valiathan; Maria J Miguez; Bijal Patel; Kristopher L Arheart; Deshratn Asthana
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  Acute eosinophilic pneumonia.

Authors:  Jang Won Sohn
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-02-28

9.  Cigarette smoking-induced acute eosinophilic pneumonia: a case report including a provocation test.

Authors:  Gene Hyun Bok; Yang-Ki Kim; Young Mok Lee; Ki-Up Kim; Soo-taek Uh; Jung Hwa Hwang; Dong Won Kim
Journal:  J Korean Med Sci       Date:  2008-02       Impact factor: 2.153

10.  Clinical Characteristics and Factors Influencing the Occurrence of Acute Eosinophilic Pneumonia in Korean Military Personnel.

Authors:  Chang-gyo Yoon; Se Jin Kim; Kang Kim; Ji Eun Lee; Byung Woo Jhun
Journal:  J Korean Med Sci       Date:  2016-01-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.